The CFSRE’s NPS Discovery program is an open-access drug early warning system (EWS) operating in the United States. Our evidence-based approach leads the development of high impact reports for real-time action among public health and safety stakeholders.

We are working in collaboration with forensic science, public health, emergency medicine, and criminal justice agencies to rapidly identify emerging drugs, also known as Novel Psychoactive Substances (NPS), associated with intoxications and adverse events. Our data and results are consolidated into reports and resources to allow for the rapid dissemination of information to colleagues and affected communities.

CFSRE’s NPS Discovery is supported by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice (Award Number 15PNIJ-24-GK-00981-COAP, “Novel Psychoactive Substance Discovery, Education, and Reporting Institute”). The opinions, findings, conclusions and/or recommendations expressed in our publications and presentations are those of the author(s) and do not necessarily represent the official position or policies of the U.S. Department of Justice.

ARE YOU INTERESTED IN KEEPING UP TO DATE WITH NPS DISCOVERY? JOIN OUR LISTSERV TODAY!